Clinical trials
Acute Coronary Syndrome trials in China with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
62 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2010 | 5 |
| 2012 | 5 |
| 2013 | 4 |
| 2014 | 4 |
| 2015 | 3 |
| 2016 | 4 |
| 2017 | 5 |
| 2018 | 8 |
| 2019 | 6 |
| 2020 | 5 |
| 2021 | 2 |
| 2022 | 5 |
| 2023 | 1 |
| 2024 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 62 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Qilu Hospital of Shandong University | 4 |
| Chinese PLA General Hospital | 3 |
| The First Affiliated Hospital with Nanjing Medical University | 3 |
| Beijing AmsinoMed Medical Device Co., Ltd | 2 |
| Beijing Anzhen Hospital | 2 |
| Beijing Friendship Hospital | 2 |
| Chinese Academy of Medical Sciences, Fuwai Hospital | 2 |
| First Affiliated Hospital of Harbin Medical University | 2 |
| Guangdong Provincial Hospital of Traditional Chinese Medicine | 2 |
| Harbin Medical University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acute Coronary Syndrome | 62 |
| Coronary Disease | 5 |
| Coronary Artery Disease | 4 |
| Myocardial Ischemia | 4 |
| Arterial Occlusive Diseases | 3 |
| Chest Pain | 3 |
| Hemorrhage | 3 |
| Cardiovascular Diseases | 2 |
| Acute Aortic Syndrome | 1 |
| Angina, Stable | 1 |
Trials
Showing 1 to 25 of 62. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.